| Type: |
Conjugated Primary Antibody |
| Conjugated with: |
594, ALEXA FLUOR® |
| Host organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Protein/Peptide: |
CST9 |
| Specificity: |
This antibody reacts specifically with CST9 |
| Modification: |
No modification has been applied to this antibody |
| Modification site: |
None |
| Clonality: |
Polyclonal Antibody |
| Clone: |
Polyclonal Antibodies |
| Concentration: |
1ug per 1ul |
| Antigen Source: |
KLH conjugated synthetic peptide derived from human CST9/Cystatin 9 |
| Gene ID: |
128822 |
| Applications: |
IF(IHC-P) |
| Applications with corresponding dilutions: |
IF(IHC-P)(1:50-200) |
| Cross reactive species: |
Human (Homo sapiens) |
| Cross Reactive Species details: |
However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species |
| Background information: |
All true cystatins inhibit cysteine peptidases of the papain family, As a member of the CRES subfamily, CRES proteins lack two of the three consensus sites necessary for the cystatin inhibition of C1 cysteine proteases, Cystatin 9, Cystatin 9 is thought to play a role in hematopoietic differentiation or inflammation, Due to their expression patterns, It has also been shown to be upregulated by LPS in some cancer cell lines, The CRES (cystatin-related epididymal spermatogenic) protein defines a new subgroup in the family 2 cystatins of the cystatin superfamily, also designated CLM, is a 159 amino acid protein that is expressed in heart, it is likely that CRES proteins may perform unique and tissue-specific functions in the reproductive and neuroendocrine systems, liver, lung, placenta, skeletal muscle and pancreas, such as cathepsins, such as promyelocytic leukemia (HL-60) and myelomonocytic leukemia, while some also inhibit legumain family enzymes, The cystatin superfamily is a well-established family of cysteine protease inhibitors |
| Purification method: |
Purified by Protein A |
| Storage: |
50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA |
| Excitation emission: |
590nm/617nm |
| Synonyms: |
CLM CTES7A |
| Also known as: |
CST9 Polyclonal Antibody |
| Other name: |
Anti-CST9 Polyclonal |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody |
| Properties: |
For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
Alexa Fluor |
| Group: |
Polyclonals and antibodies |
| About: |
The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot |
| Gene target: |
CST9 |
| Short name: |
Anti-CST9 (Polyclonal) Fluor 594 |
| Technique: |
Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different |
| Label: |
ALEXA |
| Alternative name: |
ALEXA Fluor 594, antibody to-CST9 (polyclonal) |
| Alternative technique: |
polyclonals |
| Identity: |
13261 |
| Gene: |
CST9 |
More about : CST9 |
| Long gene name: |
cystatin 9 |
| Synonyms name: |
testatin |
| Locus: |
20p11, 21 |
| Discovery year: |
2004-11-26 |
| GenBank acession: |
AF494536 |
| Entrez gene record: |
128822 |
| Pubmed identfication: |
20565543 |
| RefSeq identity: |
NM_001008693, 1 |
| Classification: |
Cystatins, type 2 |
| Havana BLAST/BLAT: |
OTTHUMG00000032076 |